Previous 10 | Next 10 |
2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
2023-12-28 10:11:14 ET More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences climbs after update on Medicare coverage for glaucoma procedure Sight Sciences spikes after insider purchases Seeking Alpha’s Quan...
MENLO PARK, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, supports the dec...
2023-12-26 13:19:25 ET Gainers: RayzeBio ( RYZB ) +101% . IMAC Holdings ( BACK ) +73% . Bit Brother Limited ( BETS ) +63% . Gracell Biotechnological ( GRCL ) +60% . Volcon ( VLCN ) +54% . Sight Sciences ( SGHT ) +45% ...
2023-12-26 12:21:27 ET More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences spikes after insider purchases Sight Sciences slumps amid risk for Medicare coverage for glaucoma procedure Seeking Alpha’s Quant ...
MENLO PARK, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...
Prospective, long-term trial results are consistent with the significant body of published clinical evidence demonstrating the durable safety and effectiveness of procedures enabled with the OMNI Surgical System technology MENLO PARK, Calif., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Sight Scienc...
2023-12-02 12:30:00 ET Summary The average stock in the large-cap Russell 1,000 rose 9.77% in November, and 38 stocks gained more than 30%, 14 rallied more than 40%, and seven surged more than 50%. We've expanded the universe to show the top-performing stocks in the Russell 3000 i...
2023-11-24 13:07:26 ET More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences slumps amid risk for Medicare coverage for glaucoma procedure Piper Sandler cuts Sight Sciences to neutral, cites lowered guidance Seekin...
2023-11-11 12:38:03 ET Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Conference Call November 07, 2023 04:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group Paul Badawi - Founder and Chief Executive Officer Ali Bauerlein - Chief Fina...
News, Short Squeeze, Breakout and More Instantly...
2024-06-17 00:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MENLO PARK, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of ...
MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform car...